These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3908741)

  • 41. Lymphokines inhibit macrophage RNA synthesis.
    Varesio L; Issaq HJ; Kowal R; Bonvini E; Taramelli D
    Cell Immunol; 1984 Mar; 84(1):51-64. PubMed ID: 6199124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of macrophages for antimycobacterial activity.
    Lowrie DB; Jackett PS; Andrew PW
    Immunol Lett; 1985; 11(3-4):195-203. PubMed ID: 3936782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines.
    Nagao S; Tanaka A; Onozaki K; Hashimoto T
    Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of macrophage activation on the response to migration inhibitory factor (MIF).
    Leu RW; Woodson PD; Whitley SB
    J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
    [No Abstract]   [Full Text] [Related]  

  • 47. Identity of specific macrophage-active human lymphokines.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    Lancet; 1978 Apr; 1(8066):718-9. PubMed ID: 76257
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of heparin on chemotactic and migration inhibitory lymphokines.
    Yoshida T; Amsden A; Ksiazek J; Cohen S
    Clin Immunol Immunopathol; 1978 Jul; 10(3):287-91. PubMed ID: 352595
    [No Abstract]   [Full Text] [Related]  

  • 49. [Influences of inflammatory macrophages on the proliferation of mouse tumor cells in vitro].
    Sun DM; Hu XZ; Shi W; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):247-9. PubMed ID: 3093180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lotus tetragonolobus fucolectin as a potential model for "MIF-like" modulation of macrophage function: comparison of the interaction of Lotus fucose binding protein (FBP) and migration inhibitory factor (MIF) with macrophages in the migration inhibition assay.
    Leu RW; Whitley SB; Herriott J; Huddleston DJ
    Cell Immunol; 1980 Jul; 52(2):414-28. PubMed ID: 7002321
    [No Abstract]   [Full Text] [Related]  

  • 51. Current state of studies of mediators of cellular immunity: a progress report.
    Cell Immunol; 1977 Oct; 33(2):233-44. PubMed ID: 334378
    [No Abstract]   [Full Text] [Related]  

  • 52. Stimulation of pinocytosis in the macrophage by lymphocyte mediators. I. Description of the phenomenon.
    Schubert RD; Wong J; David JR
    Cell Immunol; 1980 Sep; 55(1):145-54. PubMed ID: 7000370
    [No Abstract]   [Full Text] [Related]  

  • 53. Activation of rat and human alveolar macrophage intracellular microbicidal activity by a preformed LGL cytokine.
    Gomez J; Pohajdak B; O'Neill S; Wilkins J; Greenberg AH
    J Immunol; 1985 Aug; 135(2):1194-200. PubMed ID: 3925001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The macrophage as a cytotoxic effector cell.
    Lohmann-Matthes ML
    Haematol Blood Transfus; 1981; 27():49-57. PubMed ID: 7035303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP.
    Block LH; Aloni B; Biemesderfer D; Kashgarian M; Bitensky MW
    J Immunol; 1978 Oct; 121(4):1416-21. PubMed ID: 212481
    [No Abstract]   [Full Text] [Related]  

  • 56. Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma.
    Jones CM; Braatz JA; Herberman RB
    Nature; 1981 Jun; 291(5815):502-3. PubMed ID: 7015153
    [No Abstract]   [Full Text] [Related]  

  • 57. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of cadmium, lead, and zinc on the ability of guinea pig macrophages to interact with macrophage migration inhibitory factor.
    Kiremidjian-Schumacher L; Stotzky G; Dickstein RA; Schwartz J
    Environ Res; 1981 Feb; 24(1):106-16. PubMed ID: 7011794
    [No Abstract]   [Full Text] [Related]  

  • 59. Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2.
    Krammer PH; Kubelka CF; Falk W; Ruppel A
    J Immunol; 1985 Nov; 135(5):3258-63. PubMed ID: 3930600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphokine responses to concanavalin A stimulation: association with HLA DR antigens.
    MacSween JM; Eastwood SL; Cohen AD; Rajaraman K; Fox RA
    Clin Immunol Immunopathol; 1984 Sep; 32(3):368-77. PubMed ID: 6380845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.